Talk:Management Committee MitoEAGLE: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
:::# Β» [[MC MITOEAGLE e-VOTE 01]] closed | :::# Β» [[MC MITOEAGLE e-VOTE 01]] closed | ||
:::# Β» | :::# Β» [[MC MITOEAGLE e-VOTE 02]] closed | ||
== Core Group == | == Core Group == |
Revision as of 12:32, 28 October 2016
MC MITOEAGLE e-VOTES
- Β» MC MITOEAGLE e-VOTE 01 closed
- Β» MC MITOEAGLE e-VOTE 02 closed
Core Group
- The Core Group is typically composed of the Action Chair, Vice Chair, Grant Holder Scientific Representative, WG Leaders, STSM and TS coordinators and any other horizontal role (i.e. about 10-12 persons). The CG meets to take decisions on behalf of the MC (if the CG has the formal mandate to do so by the MC), and otherwise to steer the Action and submits a list of decisions for the MC to approve. It is not compulsory to have a CG, especially in smaller Actions.
- A CG meeting is therefore useful during a GP in addition to the compulsory MC, to (re)define the Actionβs activities, in particular when there is budget under- or over-spending. - Dr. Federica Ortelli (COST Science Officer) (2016)